Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities
A Bogut, B Stojanovic, M Jovanovic… - International Journal of …, 2023 - mdpi.com
Pancreatic Ductal Adenocarcinoma (PDAC) remains one of the most challenging
malignancies to treat, with a complex interplay of molecular pathways contributing to its …
malignancies to treat, with a complex interplay of molecular pathways contributing to its …